A detailed history of Captrust Financial Advisors transactions in Illumina, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 8,576 shares of ILMN stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,576
Previous 8,052 6.51%
Holding current value
$1.16 Million
Previous $840,000 33.1%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$105.28 - $135.9 $55,166 - $71,211
524 Added 6.51%
8,576 $1.12 Million
Q2 2024

Aug 14, 2024

BUY
$101.05 - $133.57 $22,129 - $29,251
219 Added 2.8%
8,052 $840,000
Q1 2024

May 15, 2024

SELL
$127.73 - $147.2 $3.51 Million - $4.04 Million
-27,454 Reduced 77.8%
7,833 $1.08 Million
Q4 2023

Feb 14, 2024

BUY
$92.79 - $142.53 $152,639 - $234,461
1,645 Added 4.89%
35,287 $4.91 Million
Q3 2023

Nov 14, 2023

SELL
$128.91 - $192.44 $221,596 - $330,804
-1,719 Reduced 4.86%
33,642 $4.62 Million
Q2 2023

Aug 14, 2023

BUY
$183.43 - $232.67 $529,012 - $671,020
2,884 Added 8.88%
35,361 $6.63 Million
Q1 2023

May 15, 2023

SELL
$193.75 - $232.55 $67,037 - $80,462
-346 Reduced 1.05%
32,477 $7.55 Million
Q4 2022

Feb 15, 2023

BUY
$187.24 - $242.74 $4.45 Million - $5.77 Million
23,756 Added 262.01%
32,823 $6.64 Million
Q3 2022

Nov 16, 2022

SELL
$177.23 - $227.44 $35,268 - $45,260
-199 Reduced 2.15%
9,067 $1.73 Million
Q2 2022

Aug 23, 2022

SELL
$181.58 - $368.0 $57,924 - $117,392
-319 Reduced 3.33%
9,266 $1.71 Million
Q2 2022

Aug 16, 2022

SELL
$181.58 - $368.0 $28,508 - $57,776
-157 Reduced 1.61%
9,585 $1.77 Million
Q1 2022

May 16, 2022

SELL
$303.87 - $423.8 $184,449 - $257,246
-607 Reduced 5.87%
9,742 $3.4 Million
Q4 2021

Feb 14, 2022

SELL
$347.28 - $421.83 $725,467 - $881,202
-2,089 Reduced 16.8%
10,349 $3.94 Million
Q3 2021

Nov 16, 2021

BUY
$405.61 - $524.84 $376,406 - $487,051
928 Added 8.06%
12,438 $5.05 Million
Q2 2021

Aug 16, 2021

SELL
$372.84 - $481.5 $349,723 - $451,647
-938 Reduced 7.54%
11,510 $5.45 Million
Q1 2021

May 17, 2021

BUY
$361.28 - $504.76 $436,426 - $609,750
1,208 Added 10.75%
12,448 $4.78 Million
Q4 2020

Feb 16, 2021

BUY
$292.7 - $370.96 $132,593 - $168,044
453 Added 4.2%
11,240 $4.16 Million
Q3 2020

Nov 17, 2020

BUY
$268.51 - $400.74 $95,858 - $143,064
357 Added 3.42%
10,787 $3.34 Million
Q2 2020

Aug 14, 2020

BUY
$256.46 - $373.01 $254,151 - $369,652
991 Added 10.5%
10,430 $3.84 Million
Q1 2020

May 15, 2020

SELL
$209.2 - $335.53 $14,225 - $22,816
-68 Reduced 0.72%
9,439 $2.42 Million
Q4 2019

Feb 14, 2020

BUY
$288.29 - $335.49 $2.67 Million - $3.11 Million
9,257 Added 3702.8%
9,507 $3.11 Million
Q3 2019

Nov 14, 2019

SELL
$266.84 - $378.23 $22,147 - $31,393
-83 Reduced 24.92%
250 $76,000
Q2 2019

Aug 13, 2019

BUY
$300.59 - $368.15 $44,487 - $54,486
148 Added 80.0%
333 $123,000
Q1 2019

May 15, 2019

BUY
$272.57 - $321.18 $1,362 - $1,605
5 Added 2.78%
185 $57,000
Q3 2018

Nov 15, 2018

SELL
$279.04 - $367.06 $172,446 - $226,843
-618 Reduced 77.44%
180 $66,000
Q2 2018

Aug 13, 2018

BUY
$228.17 - $292.07 $9,811 - $12,559
43 Added 5.7%
798 $223,000
Q4 2017

Feb 14, 2018

BUY
$202.23 - $230.03 $152,683 - $173,672
755
755 $165,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.2B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.